The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

  1. Martínez-López, J.
  2. Mustjoki, S.
  3. Porkka, K.
  4. Klisovic, R.B.
  5. Wolf, D.
  6. Busque, L.
  7. Hernández-Boluda, J.C.
  8. Swanink, R.
  9. Martin Regueira, P.
  10. Lipton, J.H.
Aldizkaria:
Leukemia and Lymphoma

ISSN: 1029-2403 1042-8194

Argitalpen urtea: 2021

Alea: 62

Zenbakia: 8

Orrialdeak: 2040-2043

Mota: Gutuna

DOI: 10.1080/10428194.2021.1889536 GOOGLE SCHOLAR